Clinical Trial Update: Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas [NA]

View source ↗

Summary

Investigates regorafenib as maintenance therapy after first-line treatment in patients with bone sarcomas and related subtypes. The trial is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Bone Sarcoma
• Chondrosarcoma
• Ewing Sarcoma
• Leiomyosarcoma
• Osteosarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Bone Sarcoma, Osteosarcoma | NA | Status: RECRUITING